Article info

Download PDFPDF
Clinical Science
Duration of action of intravitreal ranibizumab and bevacizumab in exudative AMD eyes based on macular volume measurements
  1. Correspondence to Dr L V Del Priore, 635 West 165th Street, New York, NY 10032, USA; ldelpriore{at}yahoo.com
View Full Text

Citation

Shah AR, Priore LVD
Duration of action of intravitreal ranibizumab and bevacizumab in exudative AMD eyes based on macular volume measurements

Publication history

  • Accepted March 2, 2009
  • First published May 7, 2009.
Online issue publication 
July 24, 2009

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.